RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS 04618793190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-07-12 for RUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS 04618793190 manufactured by Roche Diagnostics.

Event Text Entries

[114039015] This event occurred in (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[114039016] The customer was evaluating the cobas e 411 immunoassay analyzer with 40 patient samples tested for elecsys rubella igg immunoassay (rubella igg) compared to 2 other unspecified clia instruments. Of the 40 patient samples, the results for 3 patient samples were false negative. On (b)(6) 2018 patient 1 result from the e411 analyzer was 3. 79 iu/ml (negative). The results from the unspecified clia instruments were 14. 5 (positive) and 15. 0 (positive). On (b)(6) 2018 patient 2 (female) result from the e411 analyzer was 7. 34 iu/ml (negative). The results from the unspecified clia instruments were 12. 0 (positive) and 10. 0 (positive). On (b)(6) 2018 patient 3 (female) result from the e411 analyzer was 6. 94 iu/ml (negative). The results from the unspecified clia instruments were 17. 2 (positive) and 15. 0 (positive). The 3 patient samples were also sent to an external laboratory where the positive rubella igg results were confirmed by the liaison method. The customer had reported the negative results outside of the laboratory. It is not clear which results were believed to be correct. This information was requested but was not provided. There was no allegation that an adverse event occurred. The e411 analyzer serial number was (b)(4). The customer's calibration signals were found to be constantly below the specified range. The patient samples are no longer available for investigation. Since sample material is not available, the investigation could not be completed. The investigation was unable to determine a definitive root cause.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2018-02251
MDR Report Key7681008
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-07-12
Date of Report2018-07-12
Date of Event2018-03-05
Date Mfgr Received2018-06-26
Date Added to Maude2018-07-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameRUBELLA IGG - IGG ANTIBODIES TO RUBELLA VIRUS
Generic NameENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Product CodeLFX
Date Received2018-07-12
Model NumberNA
Catalog Number04618793190
Lot Number267421
Device Expiration Date2018-07-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2018-07-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.